Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07102394
What this trial is testing

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Who this might be right for
NF1NeurofibromatosisCutaneous Neurofibroma+3 more
Johns Hopkins University 10
Not applicableActive Not RecruitingNCT03820778
What this trial is testing

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1NeurofibromaAtypical Neurofibroma+3 more
Children's National Research Institute 10
Not applicableLooking for participantsNCT06222203
What this trial is testing

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Who this might be right for
Neurofibromatosis 1Nerve Sheath Neoplasms
National Cancer Institute (NCI) 225
Not applicableEnded earlyNCT02718131
What this trial is testing

INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)

Who this might be right for
NF1Congenital Pseudarthrosis of Tibia
University of Alabama at Birmingham 5
Not applicableStudy completedNCT02422732
What this trial is testing

Functional Imaging and Reading Deficit in Children With NF1

Who this might be right for
Neurofibromatosis Type 1
University Hospital, Toulouse 25
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT03231306
What this trial is testing

Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibroma
University of Alabama at Birmingham 45
Not applicableStudy completedNCT02397967
What this trial is testing

Reading Disability in Children With NF1

Who this might be right for
Neurofibromatosis Type 1
University Hospital, Toulouse 181
Post-approval studies (Phase 4)Study completedNCT00169611
What this trial is testing

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

Who this might be right for
Neurofibromatosis Type 1
Hospices Civils de Lyon 80
Not applicableEnded earlyNCT00060008
What this trial is testing

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 18
Early research (Phase 1)Active Not RecruitingNCT04590235
What this trial is testing

Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Who this might be right for
Neurofibromatosis 1Neurofibroma Plexiform
AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT04481035
What this trial is testing

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Children's Hospital Medical Center, Cincinnati 5
Testing effectiveness (Phase 2)Study completedNCT04481048
What this trial is testing

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Children's Hospital Medical Center, Cincinnati 25
Not applicableStudy completedNCT00111384
What this trial is testing

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1Legius Syndrome
National Cancer Institute (NCI) 313
Not applicableLooking for participantsNCT07233408
What this trial is testing

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 50
Not applicableUnknownNCT04860362
What this trial is testing

Pilot Randomized Control Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

Who this might be right for
Neurofibromatosis 1Social Skills
University of Wisconsin, Milwaukee 30
Not applicableStudy completedNCT02153931
What this trial is testing

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05913037
What this trial is testing

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform NeurofibromaNF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 167
Early research (Phase 1)Active Not RecruitingNCT05101148
What this trial is testing

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 24
Testing effectiveness (Phase 2)Ended earlyNCT03504501
What this trial is testing

Synaptic Plasticity and Cognitive Function in RASopathies

Who this might be right for
Impaired Synaptic PlasticityImpaired Cognition
Technical University of Munich 16
Next Page